Skip to main content
Special Feature

Working together

  • from Shaastra :: vol 05 issue 11 :: Nov 2026
A research scholar uses an IISERengineered catalyst for borylation of carboxylic acids.

A breakthrough solution opens new possibilities for drug discovery and chemical synthesis.

Imagine changing a single brick in a finished wall without touching the rest. For organic chemists, who make and modify carbon-based molecules, that is an everyday challenge. A molecule has many bonds, and a useful reaction must pick out just one. In drug research, a small structural change can alter how a compound dissolves, behaves in the body, or binds its target. 

Chemists at the Indian Institute of Science Education and Research (IISER) Pune may have solved a long-standing version of this puzzle. The team, led by Buddhadeb Chattopadhyay, an Associate Professor of Chemistry, has found a way to modify the far end of an aromatic carboxylic acid, a molecule commonly found in medicines, without disguising its acid group. Aromatic carboxylic acids pair a flat ring of carbon atoms with an acid group. The motif appears in medicines such as ibuprofen, naproxen, and mefenamic acid, and chemists can convert it into esters, amides and other groups. 

The problem is that the acid tends to interfere with the metal catalysts used for such reactions. For their experiments, the IISER team used benzoic acid, a simple form of aromatic carboxylic acid, which has a flat ring of six carbon atoms and an attached acid group (—COOH). This building block appears in many drugs, such as the diabetes drug repaglinide and probenecid, prescribed for gout and high levels of uric acid.

CONTINUE READING

Get unlimited digital access on any device.

Get the print magazine delivered at home.

Subscribe

PAST ISSUES - Free to Read

share-alt-square
Volume 05 Issue 10 Oct-Oct 2026
Read This Issue
share-alt-square
Volume 05 Issue 09 Sep-Sep 2026
Read This Issue
Search by Keywords, Topic or Author

© 2026 IIT MADRAS - All rights reserved

Powered by ADK RAGE